Company profile

Acthera Therapeutics AG

Mattenstrasse 22
Rosental Mitte, WRO-1059
4058 Basel
Switzerland
Biotechnology
Pharmaceutical
Biotech

Acthera Therapeutics is a preclinical-stage biopharmaceutical company. It develops hard-shelled liposomes, a nanoparticle-based technology for the targeted and controlled delivery of drugs by introducing a disruptive biophysical trigger mechanism as a powerful principle to significantly improve both efficacy and safety of many therapeutic molecules in all major disease areas.

Contact

Dr. Thierry Fumeaux
Dr. Thierry Fumeaux
Chief Operations Officer & President of PreComb Therapeutics AG

Meet us at

Share

Official program